Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer

Virology

Volumn 218, Issue 1, 1996, Pages 134-140

  Schønning, Kristian ^b   Jansson, Britt ^b   Olofsson, Sigvard ^b   Nielsen, Jens Ole ^b   Hansen, John Erik Stig ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029912187     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0173     Document Type: Article

References (34)

1. Ashkenazi, A., Smith, D. H., Marsters, S. A., Riddle, L., Gregory, T. J., Ho, D. D., and Capon, D. J. (1991). Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc. Natl. Acad. Sci. USA 88, 7056-7060.
2. Back, N. K. T., Smit, L., De Jong, J-J., Keulen, W., Schutten, M., Goudsmit, J., and Tersmitte, M. (1994). An N-glycan within the human immunodeficiency type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
3. Bou-Habib, D. C., Roderiquez, G., Oravecz, T., Berman, P. W., Lusso, P., and Norcross, M. A. (1994). Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68, 6006-6013.
4. Broder, C. C., Earl, P. L., Long, D., Abedon, S. T., Moss, B., and Doms, R. W. (1994). Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and -sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA 91, 11699-11703.
5. Daar, E. S., Li, X. L., Moudgil, T., and Ho, D. D. (1990). High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87, 6574-6578.
6. Durda, P. J., Bacheler, L., Clapham, P., Jenoski, A. M., Leece, B., Matthews, T. J., McKnight, A., Pomerantz, R., Rayner, M., and Weinhold, K. J. (1990). HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res. Hum. Retroviruses 6, 1115-1123.
7. Earl, P. L., Doms, R. W., and Moss, B. (1990). Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87, 648-652.
8. Earl, P. L., Moss, B., and Doms, R. W. (1991). Folding, interaction with GRP78-BiP, assembly and transport of human immunodeficiency virus type 1 envelope protein. J. Virol. 65, 2047-2055.
9. Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., and Moss, B. (1994). Native oligomeric human immnodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68, 3015-3026.
10. Gram, G. J., Hemming, A., Bolmstedt, A., Jansson, B., Olofsson, S., Åkerblom, L., Nielsen, J. O., and Hansen, J-E. S. (1994). Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch. Virol. 139, 253-261.
11. Hansen, J-E. S., Jansson, B., Gram, G. J., Clausen, H., Nielsen, J. O., and Olofsson, S. (1996). Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop. Arch. Virol. 141, 291-300.
12. Hansen, M. B., Nielsen, S. E., and Berg, K. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
13. Harada, S., Koyanagi, Y., and Yamamato, N. (1985). Infection of HTLV-III/LAV in HTLV-I-carrying MT-2 and MT-4 cells and application in a plaque assay. Science 229, 563-566.
14. Helseth, E., Olshevsky, U., Furman, C., and Sodroski, J. (1991). Human immunodeficiency virus type 1 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65, 2119-2123.
15. Malvoisin, E., and Wild, F. (1994). Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the host CD4 host cell receptor. J. Gen. Virol. 75, 839-847.
16. McKeating, J. A., McKnight, A., and Moore, J. P. (1991). Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralization. J. Virol. 65, 852-860.
17. Moore, J. P., and Jarrett, R. F. (1988). Sensitive ELISA for the gp120 and gp160 surface glycoprotein of HIV-1. AIDS Res. Hum. Retroviruses 4, 369-379.
18. Moore, J. P., Wallace, L. A., Follett, E. A. C., and McKeating, J. A. (1989). An enzyme-linked immunosorbent assay for antibodies to envelope glycoproteins of divergent strains of HIV-1. AIDS 3, 155-163.
19. Moore, J. P. (1990). Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. AIDS 4, 297-305.
20. Moore, J. P., Sattentau, Q. J., Wyatt, R., and Sodroski, J. (1994). Probing the structure of the human immunodeficiency virus surface glycoprotein with a panel of monoclonal antibodies. J. Virol. 68, 469-484.
21. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas III, C. F., Burton, D. R., and Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
22. Nielsen, C. M., Bygbjerg, I. C., and Vestergaard, B. F. (1987). Detection of HIV antigens in eluates of whole blood collected on filter paper. Lancet i, 566-567.
23. Pinter, A., Honnen, W. J., Tilley, S. A., Bona, C., Zaghouani, H., Gorny, M. K., and Zolla-Pazner, S. (1989). Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol. 63, 2674-2679.
24. Popovic, M., Sarnagadharan, M. G., Read, E., and Gallo, R. C. (1984). Detection isolation and continuos production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500.
25. Poumbourios, P., McPhee, A., and Kemp, B. E. (1992). Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative l-helical region. AIDS Res. Hum. Retroviruses 8, 2055-2062.
26. Poumbourios, P., El Ahmar, W., McPhee, D. A., and Kemp, B. E. (1995). Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 69, 1209-1218.
27. Reed, L. J., and Muench, H. (1938). A simple method for estimating 50% endpoint. Am. J. Hyg. 27, 493-497.
28. Sattentau, Q. J., and Moore, J. P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182, 185-196.
29. Schawaller, M., Smith, G. E., Skehel, J. J., and Wiley, D. C. (1989). Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology 172, 367-369.
30. Schønning, K., Jansson, B., Olofsson, S., and Hansen, J-E. S. (1996). Rapid selection of an N-linked oligosaccharide by monoclonal antibodies against the V3-loop of human immunodeficiency virus type 1 (HIV-1). J. Gen. Virol. 77, 753-758.
31. Stamatatos, L., and Cheng-Mayer, C. (1995). Structural modulations of the envelope gp120 glycoprotein of human immuodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol. 69, 6191-6198.
32. Sullivan, N., Sun, Y., Hofmann, W., and Sodroski, J. (1995). Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency type 1 isolates. J. Virol. 69, 4413-4422.
33. Turner, S., Tizard, R., DeMarinis, J., Pepinsky, R. B., Zullo, J., Schooley, R., and Fisher, R. (1992). Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89, 1335-1339.
34. Yewdell, J. W. A., Yellen, A., and Bachi, T. (1988). Monoclonal antibodies localize events in the folding, assembly and intracellular transport of the influenza virus hemagglutinin glycoprotein. Cell 52, 843-852.